Issue Date: May 18, 2009
NIH To Develop Drug Pipeline For Rare Diseases
NIH plans to invest $24 million a year for the next five years to jump-start an agency-wide effort called Therapeutics for Rare & Neglected Diseases (TRND). The initiative is expected to create within NIH a pipeline of new treatments for such diseases. The agency defines rare diseases as those that afflict fewer than 200,000 Americans. NIH estimates that there are more than 6,800 rare diseases, but only about 200 of them have effective pharmacologic treatments. . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society